SUNNYVALE, Calif., Jan. 20, 2026 /PRNewswire/ — Cepheid announced today that it has received FDA clearance for Xpert GI Panel, a multiplex PCR test designed to provide fast and accurate detection of 11 clinically relevant gastrointestinal (GI) pathogens from a single patient sample. Leveraging Cepheid’s advanced 10-color multiplexing technology on its GeneXpert^® systems, the test offers a robust solution to simplify GI testing workflows and deliver meaningful answers to clinicians. 

Cepheid’s Xpert GI Panel simultaneously detects and identifies 11 important bacterial, viral, and parasitic pathogens directly from stool specimens in Cary-Blair transport media. The streamlined workflow requires less than one minute of hands-on time, delivering results in approximately 74 minutes.